The medical device sector's mergers and acquisitions value beat out all other healthcare subsectors in the second quarter of 2017, based on a PwC Health Research Institute analysis, according to MD+DI.
Here are five insights:
1. In the second quarter, medical device deals were valued at $37.4 billion.
2. Two deals pushed this subsector into the lead:
• Becton Dickinson purchased C.R. Bard for $25.7 billion
• Medtronic sold supply lines to Cardinal Health for $6.1 billion
3. In the second quarter, 18 transactions occurred in the medical device field.
4. PwC analysts predict the medical device space will continue to see strong M&A activity.
5. The report also notes medical device companies are seeking to broaden their portfolios.